Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,029,143 papers from all fields of science
Search
Sign In
Create Free Account
Lisdexamfetamine
A prodrug of the d-isomer of amphetamine, a non-catecholamine sympathomimetic amine with central nervous system (CNS) stimulating activity. Upon…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (3)
NRP104
Vyvanse
lisdexamfetamine dimesylate
lisdexamfetamine dimesylate 30 MG Oral Capsule [Vyvanse]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Central nervous system stimulants and drugs that suppress appetite
Dushyant Kshatriya
,
N. Bello
Side effects of drugs annual
2020
Corpus ID: 142879433
2019
2019
Assessment of comorbidity and social anxiety in adolescents with attention deficit hyperactivity disorder: The SELFIE study
María Jesús Mardomingo Sanz
,
Carlos Sancho Mateo
,
Begoña Soler López
,
en representación del grupo de investigación del estu Selfie
,
Anexo . Grupo de estudio Selfie
Anales de Pediatría (English Edition)
2019
Corpus ID: 53713037
2017
2017
Potential for Dependence on Lisdexamfetamine - In vivo and In vitro Aspects
Jaesuk Yun
,
Kwang-Wook Lee
,
+6 authors
Hye Jin Cha
Biomolecules & Therapeutics
2017
Corpus ID: 27047209
Although lisdexamfetamine is used as a recreational drug, little research exists regarding its potential for dependence or its…
Expand
2016
2016
Epidermal necrosis with multinucleated keratinocytes: a possible diagnostic clue for dermatitis artefacta in children
S. Amin
,
O. Yélamos
,
+7 authors
J. Guitart
Journal of the European Academy of Dermatology…
2016
Corpus ID: 9561464
Editor Dermatitis artefacta (DA) is a rare disorder, characterized by self-inflicted cutaneous lesions. DA typically occurs in…
Expand
2015
2015
Circumspectives: The Replacements
M. Heilig
,
W. Carlezon
Neuropsychopharmacology
2015
Corpus ID: 34879913
In this issue we present our third Circumspectives. The purpose of a Circumspectives article is to consider an issue from…
Expand
2015
2015
Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study
M. V. Hansen
,
L. Darling
,
H. Holst
CNS Drugs
2015
Corpus ID: 19152888
BackgroundAttention-deficit hyperactivity disorder (ADHD) is a common neurobehavioural disorder in children. Pharmacotherapy…
Expand
Review
2014
Review
2014
Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
N. Maneeton
,
B. Maneeton
,
S. Suttajit
,
J. Reungyos
,
M. Srisurapanont
,
S. Martin
Drug Design, Development and Therapy
2014
Corpus ID: 1625917
Background Recent studies have promised that lisdexamfetamine (LDX) is effective in the treatment of adults with attention…
Expand
2014
2014
Clinical Effects of Lisdexamfetamine and Mixed Amphetamine Salts Immediate Release in Adult ADHD: Results of a Crossover Design Clinical Trial
L. Adler
,
Samuel Alperin
,
Terry L. Leon
,
S. Faraone
Postgraduate medicine
2014
Corpus ID: 37114515
Abstract Objectives: To examine the clinical effects of equivalent doses of single-blind (SB; patient-blind) lisdexamfetamine…
Expand
2014
2014
A pilot study of stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD) who are parents of adolescents with ADHD: the acute effects of stimulant medication on observed…
Dara E. Babinski
,
James G. Waxmonsky
,
+7 authors
W. Pelham
Journal of child and adolescent…
2014
Corpus ID: 20058090
OBJECTIVE This study explores the use of stimulant medication for parents with attention-deficit/hyperactivity disorder (ADHD…
Expand
2013
2013
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications
J. Setyawan
,
A. Guerin
,
+4 authors
M. Haim Erder
Journal of Medical Economics
2013
Corpus ID: 45904524
Abstract Objective: To compare treatment persistence in attention-deficit/hyperactivity disorder (ADHD) of patients initiated on…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE